OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
Ellen M. Apperloo, José Luis Górriz, María José Soler, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 16
Ellen M. Apperloo, José Luis Górriz, María José Soler, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 16
Showing 16 citing articles:
How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology (2025)
Open Access | Times Cited: 3
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology (2025)
Open Access | Times Cited: 3
Obesity: Recent Advances and Future Perspectives
Miodrag Janić, Andrej Janež, Mohamed El‐Tanani, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 368-368
Open Access | Times Cited: 1
Miodrag Janić, Andrej Janež, Mohamed El‐Tanani, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 368-368
Open Access | Times Cited: 1
Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond
Labib Imran Faruque, Kevin Yau, David Z.I. Cherney
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
Labib Imran Faruque, Kevin Yau, David Z.I. Cherney
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
GLP-1 Receptor Agonists for CKD: Remaining Issues or Mission Complete?
Vanja Kosjerina, Peter Rossing
American Journal of Kidney Diseases (2025)
Closed Access
Vanja Kosjerina, Peter Rossing
American Journal of Kidney Diseases (2025)
Closed Access
Effectiveness of Semaglutide in Overweight or Obese Patients With IgA Nephropathy Without Diabetes
Feng‐Lei Si, Chen Tang, Pei Chen, et al.
Nephrology (2025) Vol. 30, Iss. 4
Closed Access
Feng‐Lei Si, Chen Tang, Pei Chen, et al.
Nephrology (2025) Vol. 30, Iss. 4
Closed Access
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Milton Packer, Michael R. Zile, Christopher M. Kramer, et al.
Journal of the American College of Cardiology (2025)
Open Access
Milton Packer, Michael R. Zile, Christopher M. Kramer, et al.
Journal of the American College of Cardiology (2025)
Open Access
The effect of retatrutide on kidney parameters in participants with type 2 diabetes and/or obesity
Hiddo J.L. Heerspink, Zeqing Lu, Yu Du, et al.
Kidney International Reports (2025)
Open Access
Hiddo J.L. Heerspink, Zeqing Lu, Yu Du, et al.
Kidney International Reports (2025)
Open Access
Avances farmacológicos en la lucha contra la obesidad
Pablo Caballero Portero
Panorama actual del medicamento (2025) Vol. 49, Iss. 481, pp. 154-182
Closed Access
Pablo Caballero Portero
Panorama actual del medicamento (2025) Vol. 49, Iss. 481, pp. 154-182
Closed Access
Inkretine für CKD-Patienten
Leonie Kraft, Jörg Latus, Moritz Schanz
Deleted Journal (2025)
Closed Access
Leonie Kraft, Jörg Latus, Moritz Schanz
Deleted Journal (2025)
Closed Access
The Future of Glucagon-Like Peptide-1 Receptor Agonists In Cardiovascular–Kidney–Metabolic Diseases
Matias Trillini, Trond Jenssen, William P. Martin, et al.
Nephrology Dialysis Transplantation (2025)
Closed Access
Matias Trillini, Trond Jenssen, William P. Martin, et al.
Nephrology Dialysis Transplantation (2025)
Closed Access
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access
Bariatric Surgery for Diabetic Obesity: Insights and Challenges
Liqi Li, Mengzhe Wang
Obesity Surgery (2024)
Open Access
Liqi Li, Mengzhe Wang
Obesity Surgery (2024)
Open Access
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Miodrag Janić, Sabina Škrgat, Matevž Harlander, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2030-2030
Open Access
Miodrag Janić, Sabina Škrgat, Matevž Harlander, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2030-2030
Open Access
Actualización del posicionamiento sobre obesidad y enfermedad cardiovascular y renal de las Asociaciones de Cardiología Preventiva, Cardiología Clínica e Insuficiencia Cardiaca de la SEC
Almudena Castro Conde, Juan José Gorgojo Martínez, Nicolás Manito Lorite
REC CardioClinics (2024)
Closed Access
Almudena Castro Conde, Juan José Gorgojo Martínez, Nicolás Manito Lorite
REC CardioClinics (2024)
Closed Access
Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease
Brendon L. Neuen, Emily K. Yeung, Janani Rangaswami, et al.
Nephrology Dialysis Transplantation (2024) Vol. 40, Iss. Supplement_1, pp. i59-i69
Open Access
Brendon L. Neuen, Emily K. Yeung, Janani Rangaswami, et al.
Nephrology Dialysis Transplantation (2024) Vol. 40, Iss. Supplement_1, pp. i59-i69
Open Access
